Utility of inflammatory markers in detection of perioperative morbidity after laparoscopic sleeve gastrectomy, laparoscopic Roux-en-Y gastric bypass, and one-anastomosis gastric bypass : multicenter study by Wysocki, Michał et al.
ORIGINAL CONTRIBUTIONS
Utility of Inflammatory Markers in Detection of Perioperative
Morbidity After Laparoscopic Sleeve Gastrectomy, Laparoscopic
Roux-en-Y Gastric Bypass, and One-Anastomosis Gastric
Bypass—Multicenter Study
Michał Wysocki1 & Piotr Małczak1 & Mateusz Wierdak1 & Maciej Walędziak2 & Hady Razak Hady3 & Inna Diemieszczyk3 &
Monika Proczko-Stepaniak4 & Michał Szymański4 & Natalia Dowgiałło-Wnukiewicz5 & Jacek Szeliga6 &
Michał Pędziwiatr1 & Piotr Major1
Published online: 28 April 2020
# The Author(s) 2020
Abstract
Background The most commonly performed bariatric operations are laparoscopic sleeve gastrectomy (LSG) and bypass surgeries
(laparoscopic one-anastomosis gastric bypass (OAGB) and laparoscopic Roux-en-Y gastric bypass (LRYGB)), and predicting perioper-
ativemorbidity is crucial for early, safe patient discharge.We aimed to determinewhether C-reactive protein (CRP) andwhite blood count
(WBC) measured on the first postoperative day predicts perioperative morbidity in the first 30-days after LSG and bypass surgeries.
Methods We retrospectively analyzed data for 1400 patients who underwent bariatric surgery in seven bariatric centers from
2014 to 2018. Patients were divided into a complicated group (patients with postoperative complications) and a non-complicated
group. We also performed separate analyses for LSG and bypass surgeries.
Results Patients were 929 women (66%) and 471 men (34%) with a median age of 42 years (range, 35–51 years); 1192 patients
underwent LSG (85%), 120 underwent LRYGB (9%), and 80 underwent OAGB (6%). We performed ROC analyses to set cut-
off points, followed by multivariate logistic regressions. CRP > 33.32 mg/L increased the odds ratio (OR) of perioperative
complications after LSG 2.27 times, while WBC > 12.15 × 103/μL on postoperative day 1 was associated with a 3.34-times
greater or of developing complications. WBC > 13.78 × 103/μL was associated with a 13.34-times higher or of perioperative
morbidity in patients undergoing bypass surgeries.
Conclusion Even slightly elevated CRP and WBC on postoperative day 1 should alert surgeons to the potential risk of periop-
erative morbidity.
Keywords Laparoscopic sleeve gastrectomy . Laparoscopic Roux-en-Y gastric bypass . One-anastomosis gastric bypass . CRP .



























Extended author information available on the last page of the article
Introduction
The number of bariatric procedures is increasing annually.
According to the 2016 International Federation for the
Surgery of Obesity and Metabolic Disorders (IFSO) survey
data from 58/62 IFSO Societies, the total number of bariatric/
metabolic procedures performed in 2016 was 685,874. The
most common primary surgical bariatric/metabolic procedure
was laparoscopic sleeve gastrectomy (LSG) (340,550;
53.6%), followed by Roux-en-Y gastric bypass (LRYGB)
(191,326; 30.1%), and one-anastomosis gastric bypass
(OAGB) (30,563; 4.8%) [1, 2]. While the benefits of bariatric
surgery are unquestionable, namely, weight loss and remission
of comorbidities, surgeons must consider the risk of compli-
cations, especially because bariatric surgery is an elective pro-
cedure. The perioperative morbidity for all Clavien–Dindo
complication grades after bariatric surgery is relatively low
at 10.1%, with treatment according to the Enhanced
Recovery After Bariatric Surgery (ERABS) protocol [3].
Once complications occur, they are an issue for both the pa-
tient and the surgeon. Length of hospital stay (LOS) after
bariatric surgery is ≤ 3 days, which limits close patient moni-
toring postoperatively [4]. Therefore, it is particularly impor-
tant to identify specific markers for early detection of compli-
cations. In centers with implemented ERAS and ERABS pro-
tocols, discharges from hospital usually occur at postoperative
day (POD) 2, sometimes at POD 1 [3, 5]. The goal of this
study was to find early markers, even nonspecific, i.e., without
highest sensitivity and specificity possible. Those markers
would indicate patients, who potentially develop perioperative
morbidity and who should have more attention and probably
should stay longer at hospital. Inflammatory marker measure-
ment may achieve this goal and has met similar targets in
several surgical fields [6–10]. We aimed to determine the cor-
relations between C-reactive protein (CRP) and white blood
count (WBC), both measured routinely on the first POD, and




This was a retrospective cohort study analyzing data for pa-
tients who underwent surgical treatment for morbid obesity in
seven referral bariatric centers from February 2014 to
March 2018. Each participating center provided specific data,
which were processed and used in the overall analysis. The
study was designed and performed according to the STROBE
guidelines for observational studies [11]. The included pa-
tients underwent LSG, LRYGB, or OAGB, which are the
most commonly performed bariatric procedures in these
centers. Exclusion criteria were revision surgeries; bariatric
operations other than LSG, LRYGB, or OAGB; extended sur-
geries during which other procedures were performed; and
lack of necessary data or patients lost to follow-up. All bariat-
ric operations in the participating centers were performed
laparoscopically using comparable surgical techniques, and
perioperative care was performed according to enhanced re-
covery after surgery protocols (ERAS® [3, 5, 12]), which
ensured reliable data comparison. Part of our study was a
review of the medical records from the databases of the par-
ticipating centers. Baseline patients’ characteristics were sex,
age, bodymass index, relevant comorbidities, and the bariatric
procedure.
The primary endpoint was determining the usefulness of
routinely tested inflammatory markers on POD 1, i.e., CRP
and WBC, to predict postoperative morbidity after LSG,
LRYGB, and OAGB.
Patients were divided into two groups: a complicated group
constituting patients with postoperative complications, and a
non-complicated group constituting patients without postop-
erative complications. Additionally, patients’ data were ana-
lyzed separately for LSG and gastric bypass (LRYGB and
OAGB).
We defined postoperative morbidity as any deviation from
the standard postoperative course requiring additional ade-
quate treatment measures within 30 days of the initial proce-
dure classified according to the Clavien–Dindo grading sys-
tem [13]. LOS was defined as the period from surgery to
discharge. Prolonged LOS was defined as > 4 days because,
depending on the treatment protocols in participating centers,
planned hospitalization time for bariatric surgery was 3 or
4 days. Readmissions were analyzed only if they occurred in
the index hospitals.
CRP and WBC were measured at each participating center
on POD 1 in hospital laboratories with ISO 9001 certificates,
using comparable laboratory methods. CRP was measured in
blood serum using an immunonephelometric technique, and
WBC was measured in full blood samples preserved with
ethylenediaminetetraacetic acid, using flow cytometry.
Statistical Analysis
Statistical analyses were performed using Statistica 13.5 soft-
ware (StatSoft®, Tulsa, OK). Continuous values were pre-
sented as means with standard deviations or medians with
interquartile ranges, as appropriate. Quantitative variables
were compared using Student’s t test or the Mann–Whitney
U test, while qualitative variables were compared with the chi-
squared test with or without Yates’ correction. Optimal cut-off
points for laboratory parameters were chosen using Youden’s
index. Multivariate logistic regression models adjusted for
relevant intergroup baseline differences were performed to
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calculate odds ratios (ORs) with 95% confidence intervals
(CIs). P values ≤ 0.05 were considered statistically significant.
Study Group
The study group constituted 1400 patients from seven bariat-
ric centers with complete data for a 30-day postoperative fol-
low-up. Figure 1 is a patient flow chart. There were 929 wom-
en (66%) and 471 men (34%) in the study group, with a
median age of 42 years (range, 35–51 years); 1192 patients




Perioperative morbidity was encountered in 69 patients
(4.93%), and morbidity rates differed significantly between
LSG and bypass surgery (p < 0.001). Mortality was 0.29%
(four patients). The general characteristics of the study groups
and differences in perioperative laboratory results are present-
ed in Table 1.
Main Outcomes
Perioperativemorbidity data after LSG and bypass surgery are
presented in Table 2.
Regarding the cut-off points for CRP and WBC for periop-
erative complications, we determined these separately for
LSG and bypass surgery. We were able to determine the cut-
off points for all analyzed inflammatory markers for LSG for
general morbidity and morbidity of III–V Clavien–Dindo
grades; however, for LRYGB and OAGB, we were able to
determine a significant cut-off for only WBC on POD 1
(Table 3).
The cut-off points and other possible risk factors for peri-
operative morbidity after LSG were analyzed in logistic re-
gression models and are presented in Table 4. Factors that
were significant in the univariate logistic regression models
were selected for multivariate analyses. CRP > 33.32 mg/L
and WBC > 12.15 × 103/μL on POD 1, and longer operating
time with LSG, were prognostic factors for LSG-related mor-
bidity (Table 4).
Then, the same analyses were created for perioperative
morbidity of III–V Clavien–Dindo grades after LSG. WBC
on POD 1 > 12.2 × 103/μL, determined in the ROC analysis
was the only significant risk factor for perioperative morbidity
of III–V Clavien–Dindo grades after LSG (Table 5).
We analyzed the cut-off points and other possible risk fac-
tors for perioperative morbidity after LRYGB and OAGB
using logistic regression models, and results are presented in
Table 5. In the univariate analyses, type 2 diabetes and WBC
on POD 1 were significant risk factors. We found that type 2
diabetes and WBC > 13.78 × 103/μL on POD 1 indicated sig-
nificantly increased risk for perioperative complications after
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Fig. 1 Flow chart of patients
through the study
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In case of perioperative morbidity of III–V Clavien–Dindo
grades, the only significant parameter in univariate logistic
regression models was WBC on POD1 > 13.78 × 103/μL
(Table 7).
Discussion
Bariatric procedures are now considered standard in general
surgery in Poland. Moreover, these procedures are performed
in low-volume centers and private facilities, often as a single-
day admission or as medical tourism. Therefore, identifying
early markers predicting perioperative morbidity is needed
and relevant, as the patients are usually discharged from hos-
pital at POD 2. We found similar research and study protocols
for early markers of morbidity in other fields of general sur-
gery, particularly in colorectal surgery, but we found no stud-
ies with a large patient cohort undergoing bariatric surgery
analyzing the usefulness of CRP and WBC to predict the risk
of perioperative complications, as in our study.
We evaluated patients undergoing surgery for morbid obe-
sity in accordance with the ERAS® protocols [12]. Our pa-
tient groups were similar regarding their baseline characteris-
tics, and our results showed that CRP and WBC values dif-
fered between patients who developed complications and
those who did not. Multivariate analysis and ROC analysis
showed that CRP > 33.32 mg/L on POD 1 was associated
with a three times greater risk of developing complications,
and that WBC > 12.15 × 103/μL on POD 1 was associated
with a two times greater risk in patients undergoing LSG.
The only inflammatory marker that was significantly associ-
ated with a higher risk of morbidity after gastric bypass was
WBC > 13.78 × 103/μL on POD 1, which increased the risk
by 13 times. In case of perioperative morbidity of III–V
Clavien–Dindo grades, WBC on POD 1 remained indicative
risk factor for perioperative morbidity after LSG, as well as
bypasses.
Albanopoulos et al., in their study evaluating LSG, showed
that WBC and CRP were correlated with leakage or abscess
on PODs 3, 5, 7, 9, and 11 [6]. However, the main
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Table 1 General characteristics
patients after LSG or LRYGB and
OAGB
Complicated Non-complicated p value
LSG
n (%) 47 (3.94%) 1145 (96.06%) n/a
Males/females, n (%) 14/33 (30%/70%) 402/743 (35%/65%) 0.453
Median age, years (IQR) 40 (35–49) 41 (34–50) 0.944
Median BMI, kg/m2 (IQR) 44.46 (39.31–49.84) 43.59 (40.27–48) 0.435
Diabetes mellitus type 2, n (%) 13 (27.66%) 251 (21.96%) 0.357
Arterial hypertension, n (%) 28 (59.57%) 575 (50.22%) 0.211
Obstructive sleep apnea, n (%) 7 (14.89%) 147 (12.84%) 0.637
Median operative time, min (IQR) 75 (60–105) 70 (55.5–90) 0.113
Median LOS, days (IQR) 5 (4–7) 3 (3–4) < 0.001
Readmissions, n (%) 12 (25.53%) 9 (0.79%) < 0.001
Median CRP on POD 1, mg/L (IQR) 28.77 (15.1–48.8) 18.84 (11.6–29.6) 0.002
Median WBC on POD 1, × 103/μL (IQR) 12.42 (10.7–16.83) 11.16 (9.25–13.21) 0.002
Bypasses
n (%) 22 (10.58%) 186 (89.42%) n/a
Males/females, n (%) 9/13 (41%/59%) 46/140 (25%/75%) 0.088
Median age, years (IQR) 44 (40–50) 46 (39–54) 0.188
Median BMI, kg/m2 (IQR) 42.05 (37–46.60) 42.05 (38.30–46.66) 0.857
Diabetes mellitus type 2, n (%) 11 (50.0%) 42 (22.58%) 0.022
Arterial hypertension, n (%) 14 (63.64%) 112 (60.22%) 0.756
Obstructive sleep apnea, n (%) 4 (18.18%) 34 (18.28%) 0.965
Median operative time, min (IQR) 95 (65–150) 95 (65–150) 0.810
Median LOS, days (IQR) 4 (4–8) 3 (2–4) 0.003
Readmissions, n (%) 7 (31.82%) 5 (2.69%) < 0.001
Median CRP on POD 1, mg/L (IQR) 13.51 (6.7–27.76) 18.68 (10–41.1) 0.316
Median WBC on POD 1, × 103/μL (IQR) 15.69 (13.88–16.78) 11.28 (9.47–13.23) < 0.001
BMI, body mass index; IQR, interquartile range; LOS, length of hospital stay; CRP, C-reactive protein; WBC,
white blood count; POD, postoperative day
disadvantage of the study was the low number of patients with
complications, which rendered the conclusions difficult to in-
terpret. Mickevicius et al. presented results after LRYGB and
showed that CRP differed significantly on POD 1 between
patients with and without postoperative 30-day morbidity.
This finding differs from our results regarding LRYGB, which
indicated that differences in CRP levels were non-significant
[14]. Villard et al. identified CRP as a specific marker, how-
ever, with very low sensitivity [15]. In their study, the authors
identified CRP of 50 mg/L as a predictor of complications. In
contrast, our multivariate analysis predicted complications
when CRP was > 33.32 mg/L. The main advantage in our
analysis is that our regression models included additional fac-
tors. Williams et al. reported even higher CRP levels at >
90 mg/L on POD 1 in patients with complications and
75 mg/L in patients without complications. Warschkow et al.
suggested that CRP should be routinely measured on POD 2
after LRYGB to exclude complications, and leaks in particular
[16]. The authors concluded that radiological imaging exam-
inations for intestinal leaks could be restricted to patients with
Table 2 Perioperative morbidity
sorted out regarding Clavien–
Dindo classification of surgical
complications
C–D Perioperative LSG LRYGB and OAGB
V Urosepsis 1 0
GI leak 1 0
Intra-abdominal hernia, GI leak 0 1
Acute pancreatitis, GI leak, peritonitis 1 0
IVb Acute respiratory failure 1 0
IVa Heart failure 1 0
IIIb Subphrenic abscess 2 1
GI leak 5 3
Postoperative bleeding (reoperation) 11 3
GI stricture 0 2
IIIa GI stricture 1 1
Postoperative bleeding (treated endoscopically) 4 7
Surgical site infection 3 1
Intraperitoneal fluid collection 1 0
Subphrenic hematoma, acute pancreatitis 1 0
II Postoperative bleeding (treated with blood transfusions) 2 3
Renal insufficiency 1 0
Clostridium difficile infection 1 0
Superior mesenteric vein and/or portal vein thrombosis 2 0
Pneumonia 2 0
I Vomiting/dehydration 6 1
Total 47 (3.94%) 22 (10.58%)
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Table 3 Results of ROC analyses of CRP on POD 1 (mg/L) and WBC on POD 1 (× 103/μL) for LSG and bypasses
Cut-off point AUC (95% CI) p value Sensitivity (%) Specificity (%)
LSG
Morbidity CRP 33.32 0.66 (0.56–0.76) 0.002 47.1 80.2
WBC 12.15 0.65 (0.56–0.74) 0.001 48.7 66.9
Morbidity of III–V Clavien–Dindo CRP 35.00 0.59 (0.46–0.72) 0.048 36.4 81.5
WBC 12.20 0.69 (0.58–0.579) 0.001 66.7 63.3
Bypasses
Morbidity CRP 82.75 0.42 (0.26–0.58) 0.332 n/a n/a
WBC 13.78 0.8 (0.69–0.90) < 0.001 81.8 79.6
Morbidity of III–V Clavien–Dindo CRP 92.7 0.47 (0.25–0.69) 0.778 n/a n/a
WBC 13.78 0.79 (0.66–0.92) < 0.001 85.7 77.3
serum CRP > 229 mg/L on POD 2. Accordingly, it is difficult
to determine the exact cut-off point for CRP concentration to
predict complications.
WBC count in a study by Mickevicius et al. did not differ
between the groups. Similar results were presented by Ruiz-
Tovar et al. [17], and a study by Da Silva et al. evaluated the
correlation between neutrophil-to-lymphocyte ratio (NLR) on
POD 1 as a predictive factor for perioperative complications
[18]. Da Silva et al.’s study was a retrospective cohort study of
737 patients who underwent predominantly LRYGB, but also
LSG. The authors reported that NLR ≥ 10 on POD 1 was
associated with the following 30-day clinical outcomes:
prolonged hospital stay (> 2 days); higher incidence of overall
complications and major complications as well as higher re-
admission rate; and higher reoperation rate. On multivariable
analysis, elevated NLR retained its predictive value for all
outcome variables, except for readmissions.
Interestingly, prolonged operative time was a significant
predictor for perioperative morbidity in patients undergoing
LSG, in our study.We believe that this finding was not a result
of longer operation times, but, rather, was secondary to
Table 7 Logistic regression models of risk factors for perioperative
morbidity of III–V Clavien–Dindo after bypasses
OR 95% CI p value
Univariate
Females 0.63 0.20–1.97 0.419
Age, every year 0.96 0.91–1.02 0.165
BMI, every kg/m2 1.01 0.64–1.09 0.788
Diabetes mellitus type 2 0.45 0.14–1.50 0.193
Arterial hypertension 1.68 0.51–5.59 0.394
Obstructive sleep apnea 0.43 0.05–3.52 0.425
Operative time, every min 1.00 0.99–1.01 0.635
WBC on POD 1 > 13.78 × 103/μL 12.5 3.31–47.16 < 0.001
Multivariate
OR, odds ratio; 95%CI, 95% confidence interval; BMI, body mass index;
CRP, C-reactive protein; WBC, white blood count; POD, postoperative
day
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Table 4 Logistic regression models of risk factors for perioperative
morbidity after LSG
OR 95% CI p value
Univariate
Females 1.13 0.82–1.55 0.454
Age, every year 1.00 0.97–1.03 0.975
BMI, every kg/m2 1.02 0.98–1.07 0.268
Diabetes mellitus type 2 1.17 0.84–1.62 0.358
Arterial hypertension 1.21 0.90–1.63 0.213
Obstructive sleep apnea 1.10 0.73–1.67 0.638
Operative time, every min 1.01 1.00–1.02 0.034
CRP on POD 1 > 33.32 mg/L 3.19 1.57–6.49 0.001
WBC on POD 1 > 12.15 × 103/μL 2.20 1.15–4.21 0.018
Multivariate
Operative time, every min 1.02 1.00–1.03 0.016
CRP on POD 1 > 33.32 mg/L 2.27 1.02–5.02 0.043
WBC on POD 1 > 12.15 × 103/μL 3.34 1.54–7.25 0.002
OR, odds ratio; 95%CI, 95% confidence interval; BMI, body mass index;
CRP, C-reactive protein; WBC, white blood count; POD, postoperative
day
Table 6 Logistic regression models of risk factors for postoperative
morbidity after bypasses
OR 95% CI p value
Univariate
Females 0.48 0.19–1.18 0.110
Age 0.97 0.93–1.02 0.190
BMI 1.00 0.94–1.07 0.913
Diabetes mellitus type 2 3.23 1.12–9.09 0.029
Arterial hypertension 1.16 0.46–2.89 0.756
Obstructive sleep apnea 1.03 0.28–3.86 0.965
Operative time 1.00 0.99–1.01 0.855
CRP on POD 1, every mg/L 1.00 0.98–1.02 0.946
WBC on POD 1 > 13.78 × 103/μL 13.24 4.59–38.18 < 0.001
Multivariate
Diabetes mellitus type 2 3.13 1.04–9.48 0.043
WBC on POD 1 > 13.78 × 103/μL 13.14 4.50–38.41 < 0.001
OR, odds ratio; 95%CI, 95% confidence interval; BMI, body mass index;
CRP, C-reactive protein; WBC, white blood count; POD, postoperative
day
Table 5 Logistic regression models of risk factors for perioperative
morbidity of III–V Clavien–Dindo after LSG
OR 95% CI p value
Univariate
Females 1.07 0.49–2.36 0.859
Age, every year 0.99 0.96–1.03 0.714
BMI, every kg/m2 1.02 0.97–1.07 0.449
Diabetes mellitus type 2 1.07 0.45–2.54 0.879
Arterial hypertension 1.12 0.54–2.32 0.765
Obstructive sleep apnea 0.64 0.22–2.49 0.629
Operative time, every min 1.01 1.00–1.02 0.080
CRP on POD 1 > 35 mg/L 2.06 0.82–5.18 0.126
WBC on POD 1 > 12.2 × 103/μL 2.87 1.24–6.65 0.014
OR, odds ratio; 95%CI, 95% confidence interval; BMI, body mass index;
CRP, C-reactive protein; WBC, white blood count; POD, postoperative
day
technical difficulties or intraoperative adverse events, which
we did not analyze in this study [4, 19]. Major et al. evaluated
morbidity after LSG and reported that prolonged operation
and increased number of stapler firings were associated with
a higher risk of perioperative complications, but interestingly,
intraoperative adverse events were not directly associatedwith
an increased risk of perioperative morbidity. In another study
by Major et al., decreased oral fluid intake, the need for in-
creased intravenous fluids on the day of surgery, and longer
distance from the patient’s habitual residence to the bariatric
center were potential risk factors for prolonged hospital stay.
Intraoperative adverse events also increased the risk for hos-
pital readmission [4, 19].
In patients undergoing colorectal surgery, measuring in-
flammatory markers is now almost a routine. However, colo-
rectal surgery has different specificity and higher rates for
postoperative morbidity, and leaks are more prevalent, which
determines different cut-off points. In a meta-analysis by
Cousin et al. of the accuracy of CRP on POD 3 to diagnose
intra-abdominal infection after elective colorectal surgery, the
cut-offs varied in the studies, from 130 to 190 mg/L [20]. CRP
and procalcitonin were significantly higher much earlier than
when patients became symptomatic, at between POD 7 and
POD 9 [21–23]. This finding is crucial to understand why we
performed a similar study in bariatric surgery. Significantly
higher CRP levels were found after colorectal surgery as early
as POD 1 in patients who later developed intra-abdominal
infection, which raises doubts regarding opinions that anasto-
motic leakage occurs near POD 7 [20, 22, 24]. A stronger
inflammatory response may be both the consequence and
the cause of intra-abdominal infection (impaired healing or
reflecting ongoing tissue hypoxia leading to anastomotic leak-
age) [21, 25].
The main advantage of our study is the high patient num-
bers, which makes our conclusions more reliable. We found
no ERAS® guidelines indicating laboratory measurements
predicting postoperative morbidity. It would be useful to have
cut-off points for laboratory measurements of inflammatory
markers to select patients requiring longer postoperative stays,
for early detection and prevention of postoperative morbidity.
Short hospital stays are necessary to maintain a high bariatric
surgical volume; therefore, having laboratory criteria for early
and safe discharge from hospital would be highly beneficial
[26].
Limitations
This was a non-randomized analysis, and our groups were
demographically heterogeneous and differed regarding the
preoperative factors. Furthermore, because the data were col-
lected separately from seven bariatric centers using different
electronic systems, some necessary information was lacking
in our initial population, which caused exclusions. After
excluding incomplete records and repetitions in the collective
database, we obtained our final number of patients, which
added selection bias. Additionally, we did not record postop-
erative events, such as readmissions occurring outside the
indexed hospitals. Patients during hospital discharge were in-
formed to report to index hospital in case of any emergencies.
In case of patients that live in a long distance they could refer
to local hospitals.
Conclusion
CRP > 33.32 mg/L and WBC > 12.15 × 103/μL on POD 1
were associated with a greater risk of developing complica-
tions in patients undergoing LSG. WBC > 13.78 × 103/μL
was associated with a higher risk of morbidity in patients after
bypass surgery. Even slightly elevated CRP and WBC on
POD 1 should alert surgeons to the potential risk of perioper-
ative morbidity.
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